RxSight, Inc. (RXST) Tops Q4 EPS by 30c

RxSight, Inc. (NASDAQ: RXST) reported Q4 EPS of ($0.45), $0.30 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $15.78 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• Wolfe upgrades AT&T to Outperform as improving fundamentals outweigh Starlink risk
• Ameriprise Financial (AMP) Tops Q2 EPS by 29c
• Popular (BPOP) Tops Q2 EPS by 64c